Over 10 years experience of Traceability Solutions
By pharmatrax
Category: Technoloy
No Comments
Another innovation hub, in the southern city of Guangzhou, is planned for November. To date, six startups in China and other Asian countries have taken…
By pharmatrax
Category: Technoloy
No Comments
Such technologies, such as RFID and IIoT, help to address cold chain inefficiencies by providing increased visibility into the locations, properties, and conditions of sensitive…
By pharmatrax
Category: Technoloy
No Comments
Paul Tunnah runs through the six key aspects of digital health and how businesses can harness them. It’s that time of year again – the leaves…
By pharmatrax
Category: Technoloy
No Comments
Four big pharma experts explain the challenges companies face in adopting digital tech and what trends are likely to drive digital commercial strategies in the…
By pharmatrax
Category: Technoloy
No Comments
At the HIMSS Connected Health Conference, Bob Coughlin, president and CEO of Mass Biotech Council, offers his expert view of how these two areas of…
By pharmatrax
Category: Technoloy
No Comments
The advances in Artificial intelligence (AI) have effectively proliferated into numerous sectors, for example, computer vision, speech recognition and natural language processing. Artificial intelligence is…
By pharmatrax
Category: News
No Comments
These 3-D models of a receptor, co-receptor, and ligand demonstrate how the protein painting technology works. Bound proteins in their native form are coated with…
By pharmatrax
Category: Technoloy
No Comments
As precision medicine hones its skills and attempts to become even more personalized, pharma companies and clinical trial designs must embrace new strategies. Be sure…
By pharmatrax
Category: Technoloy
No Comments
Under regulatory pressure, a large number of pharmaceutical manufacturers, shippers and wholesalers are adopting blockchain to track and trace prescription drugs. The pharmaceutical industry in…
By pharmatrax
Category: Technoloy
No Comments
For the first time, a Toronto-based company called Deep Genomics has discovered a drug target and corresponding candidate using artificial intelligence (AI). The company announced…